Bambusa Therapeutics
Clinical trials sponsored by Bambusa Therapeutics, explained in plain language.
-
New eczema drug enters first human safety tests
Disease control Recruiting nowThis is an early-stage study to check the safety and basic effects of a new drug called BBT001. It will first test single doses in healthy volunteers, then test repeated doses in adults with moderate to severe atopic dermatitis (eczema). The main goal is to see how well people to…
Phase: PHASE1 • Sponsor: Bambusa Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for COPD patients as experimental drug enters human testing
Disease control Recruiting nowThis is the first human study of an experimental drug called BBT002 for chronic obstructive pulmonary disease (COPD). The main goal is to check if the drug is safe and how it behaves in the body, first in healthy volunteers and then in people with COPD. Researchers will give incr…
Phase: PHASE1 • Sponsor: Bambusa Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
First human tests begin for new eczema injection
Disease control Recruiting nowThis is an early-stage study to check the safety of a new drug called BBT001 for people with moderate-to-severe eczema (atopic dermatitis). Researchers will give the drug to healthy volunteers and eczema patients in increasing doses to see how well it is tolerated and how it move…
Phase: PHASE1 • Sponsor: Bambusa Therapeutics • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC